Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 May 10;3:PO.18.00283. doi: 10.1200/PO.18.00283

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2019 by American Society of Clinical Oncology

Creative Commons Attribution Non-Commercial No Derivatives 4.0 License: https://creativecommons.org/licenses/by-nc-nd/4.0/

PMC Copyright notice

FIG A4. — (A) Genome-wide loss of heterozygosity (gLOH) score was assessable for 2,624 cases, and cases with 14% or more gLOH were designated LOH-high (LOH-H). All other cases were LOH-low (LOH-L). LOH-H cases were assessed for the presence (green) or absence (yellow) of a genomic alteration (GA) in the homologous recombination repair (HRR) or Fanconi anemia/interstrand crosslink repair (FA/ICL) pathway. (B) Genes were grouped together into HRR pathway (excluding non-BRCA1/2) or FA/ICL pathway (FANC); genes were categorized as in Figure 2A. All GAs or only homozygous deletions (homdel) were assessed for LOH-H and compared with the overall data set (green). Each subset was individually compared with the overall data set, and unadjusted P values are shown (Fisher’s exact test [two-tailed]).